Amani Ali Alhajeri

Dr. Amani Ali Alhajeri


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2012 in Advances in Hematology
Verified
Journal Article
Open access
PDF file
SAShaikha Al Arrayed
Shaikha Al Arrayed
AAAmani Ali Alhajeri
Amani Ali Alhajeri
Introduction. The incidence of genetic blood disease in Bahrain has declined gradually since 1984 when the Ministry of Health (MOH) instituted a prevention campaign. The national NBS program for hemoglobinopathies was started in May 2007, financed by the national budget.Setting. Genetics department, Salmaniya Medical Complex, MOH, Bahrain.Methodology. The genetics, nursing, pathology, and pediatric departments were involved in the study. This service was offered to all infants. Cord blood samples were collected at birth and were then sent to the laboratory.Results. During 3.5 years after the program was implemented, we screened 38,940 newborns (NBs), of which 17,375 were screened in 2008, 10,248 in 2009, and 11,317 in 2010. The number of affected NBs was 128 in both 2007 and 2008, 58 in 2009, and 47 in 2010, as the average number of affected NBs in 2010 was 4 per month. The incidence of affected NBs was found to be 0.7% in 2008, 0.6% in 2009, and 0.4% in 2010.Conclusion. NBS is an essential step for the early diagnosis and treatment of affected NBs, future recurrence of the disease in the same family. In Bahrain, the number of affected NBs has declined by 75% during the last 20.

5 October 2011
Verified
Reference Entry
Closed access
PDF file
VJVanitha A Jagannath
Vanitha A Jagannath
ZFZbys Fedorowicz
Zbys Fedorowicz
AAAmani Ali Alhajeri
Amani Ali Alhajeri
NHNianfang Hu
Nianfang Hu
ASAkshay Sharma
Akshay Sharma

Verified
Journal Article
Open access
PDF file
AAAmani Ali Alhajeri
Amani Ali Alhajeri
AAAmna Al Awadhi
Amna Al Awadhi
NKNitya Kumar
Nitya Kumar
GJGhufran Jassim
Ghufran Jassim
Background: Breast cancer (BC) is the leading female cancer globally, with Bahrain having the highest incidence in the GCC. In this study, we aimed to identify and describe the high-risk pathogenic/likely pathogenic mutations in a cohort of 160 Bahraini patients who underwent genetic testing for hereditary cancer susceptibility genes. Methods: This study included 160 women referred to Bahrain’s Government Hospitals for genetic analysis between January 2021 and May 2024. All women underwent NGS cancer gene panel testing. Demographic and clinical data were recorded for each patient. Categorical variables were described using frequencies and percentages, and continuous data was depicted using means and standard deviations or medians. Results: Pathogenicity was significantly higher in individuals with high-risk mutations compared to those with medium- and low-risk mutations. However, mortality was highest among those with medium-risk mutations, exceeding that of both the high- and low-risk groups. Conclusions: In Bahrain, the genetic profile of BC germline mutations aligns closely with international data. However, further research is needed to assess moderate- and low-risk mutations and their pathogenicity within the diverse ethnic populations of the Middle East.